
August 20, 2019 Manufacturing and Production AMR, Antibiotics, C difficile, C. difficile, pharma, superbug

August 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Genomenon, Rare Genomics Institute, pharma, rare disease

August 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Air pollution, CAR-T therapy, HIV, Kymriah, Medicare, Novartis, Yescarta, Zolgensma

August 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, feature, personalised medicine, pharma

August 13, 2019 Manufacturing and Production, Research and Development Cancer, Harvard, MSD, Merck, immuno-oncology, oncology, pharma

August 13, 2019 Manufacturing and Production, Sales and Marketing Camurus, NHS, Scotland, nhs scotland, opioid dependence, opioids, pharma

August 13, 2019 Manufacturing and Production chlamydia, clinicla trials, infectious diseases, pharma, vaccines

August 13, 2019 Manufacturing and Production, Research and Development Congo, DRC, Ebola, clinical trials, infectious diseases, niaid, pharma

August 13, 2019 Manufacturing and Production Orkambi, SMC, Scotland, Vertex, cystic fibrosis, pharma

August 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, CAR T, CAR-T, Eli Lilly, Lexicon, Medicare, Novartis, Pfizer, Sanofi, pharma

August 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

August 6, 2019 Manufacturing and Production, Research and Development Eli Lilly, Emgality, migraine, pharma

August 6, 2019 Manufacturing and Production NHS, NICE, Rubraca, UK, guidance, pharma

August 6, 2019 Manufacturing and Production GPCR, Sosei Heptares, Takeda, pharma, sosei

August 6, 2019 Manufacturing and Production, Sales and Marketing EU, Europe, Sanofi, atopic dermatits, pharma